Saffran, who wants to stay on Ozempic because of its other benefits, will be lowering her dosage as well as starting minoxidil
PMID: 37952131 Efficacy and safety of semaglutide in non-diabetic adults with overweight or obesity: A meta-analysis of randomized controlled trials. European Journal of Pharmacology
Acne (especially jawline, chin, lower-face) Spironolactone went from off-label option to evidence-based first-line for adult female acne in 2023 with the SAFA trial a UK multicenter, double-blind, placebo-controlled RCT of 410 women published in The BMJ and Health Technology Assessment
The company says it is planning to initiate a Phase III development program with amycretin for adults with overweight or obesity during the first quarter of 2026
Cortisol, the bodys primary stress hormone, directly accelerates lean mass loss through muscle protein catabolism, deepens adaptive thermogenesis by dysregulating leptin and ghrelin, and drives visceral fat accumulation through glucocorticoid receptors concentrated in abdominal adipose tissue
Energy improves